The Chemours Company CC reported a net loss of $381 million or $2.54 per share for second-quarter 2025, in contrast to the year-ago quarter's net income of $60 million or 39 cents.
Barring one-time items, earnings were 58 cents per share, which beat the Zacks Consensus Estimate of 46 cents.
The company reported second-quarter net sales of $1,615 million, reflecting a 4% rise from the previous-year quarter. It also beat the Zacks Consensus Estimate of $1,568.3 million. A gain of 3% in volume and 1% in pricing resulted in the growth.
Adjusted EBITDA improved 22% year over year to $253 million for the quarter. The increase in adjusted EBITDA was primarily driven by growth in volumes, pricing and lower corporate expenses.

The Chemours Company price-consensus-eps-surprise-chart | The Chemours Company Quote
The Titanium Technologies division recorded revenues of $657 million in the quarter, marking a 3% decrease from the previous year. The figure surpassed our estimate of $640.1 million. This downside was primarily due to a 4% decrease in price, partially offset by a 1% tailwind from currency movements.
In the Thermal & Specialized Solutions segment, revenues saw a 15% year-over-year increase, reaching $597 million in the reported quarter. The figure topped our estimate of $582.6 million. Net sales growth was mainly driven by an 11% increase in volume and 4% increase in price, while the currency remained flat. Volume growth was driven by increased demand for Opteon Refrigerant blends in connection with the US AIM Act's low-GWP stationary air conditioning equipment transition. The pricing also increased due to its solid aftermarket demand.
Revenues in the Advanced Performance Materials unit amounted to $346 million, flat year over year. The figure beat our estimate of $332.9 million. The 6% decrease in volume was offset by a 6% increase in pricing due to higher prices of high-value applications and pricing opportunities in the SPS Capstone product line’s exit.
Cash used by operating activities in the first half of 2025 was $19 million compared with $910 million in the prior-year period. Capital expenditures for the second quarter were $43 million compared with $73 million in the previous-year quarter due to lower capital expenditures in the APM and TSS segments.
For the third quarter of 2025, the company expects consolidated net sales to decrease 4-6% sequentially. Adjusted EBITDA is also expected to be in the range of $175-$195 million. Corporate expenses are expected to go down by 5%. Free cash flow conversion of between 60% and 80% and capital expenditures of roughly $50 million are forecasted.
Chemours expects full-year 2025 sales between $5.9 and $6 billion and adjusted EBITDA between $775 million and $825 million. Capital expenditures are expected to be approximately $250 million.
Shares of Chemours have lost 32.1% in the past year compared with the industry’s decline of 23.1%.

CC currently carries a Zacks Rank #5 (Strong Sell).
Some better-ranked stocks worth a look in the basic materials space are Avino Silver & Gold Mines Ltd. (ASM), Gold Fields Limited GFI and Vizsla Silver Corp. VZLA.
Avino Silver is slated to report second-quarter results on Aug. 13. The Zacks Consensus Estimate for earnings is pegged at 3 cents per share. ASM’s earnings beat the Zacks Consensus Estimate in each of the last four quarters, with the average surprise being 104.2%. Avino Silver flaunts a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Gold Fields is slated to report second-quarter results on Aug. 22. The Zacks Consensus Estimate for GFI’s second-quarter earnings is pegged at 59 cents per share. Gold Fields currently sports a Zacks Rank #1.
Vizsla is expected to report quarterly results on Sept. 11. The consensus estimate for VZLA’s earnings is pegged at a loss of a penny per share. VZLA’s earnings met the Zacks Consensus Estimate in three of the last four quarters while beating it in one, with the average surprise being 75%. Vizsla sports a Zacks Rank #1 at present.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Sep-02 | |
| Aug-26 | |
| Aug-26 | |
| Aug-25 | |
| Aug-25 | |
| Aug-19 | |
| Aug-12 | |
| Aug-12 | |
| Aug-12 | |
| Aug-10 | |
| Aug-06 | |
| Aug-05 | |
| Aug-05 | |
| Aug-05 | |
| Aug-04 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite